THOMAS GAMMILL: Open Payments
NPI 1760459333 · LAKEWOOD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 17 payments from 10 companies in 2025. Trend: 2023 $979 · 2024 $911 · 2025 $406
Food & beverage: $385Education: $22
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $188 |
| Acella Pharmaceuticals, LLC | 3 | $47 |
| Exact Sciences Corporation | 1 | $29 |
| Lundbeck LLC | 1 | $29 |
| Astellas Pharma US Inc | 1 | $24 |
| PFIZER INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
Products named: FARXIGA, NP Thyroid 60, Cologuard Collection Kit, REXULTI, Veozah, BREZTRI, NURTEC ODT, ZEPBOUND.
Industry payments across WA — which companies pay providers there.
